About Nifty Labs
Nifty Labs is a Healthcare company based in Hyderabad (India) founded in 2005 by Kesava Reddy. It provides comprehensive solutions for API manufacturing and regulatory affairs. It operates on a B2B model. The company has 348 employees. Its Indian entity Nifty Labs Private Limited reported revenue of ₹207 Cr. Its focus areas include Pharmaceuticals, API Manufacturing and Regulatory Services. Its competitors include WuXi AppTec, Eurofins Scientific, Ipsen, ANI Pharmaceuticals and Red Nucleus and 4 more; 2 of its 9 listed competitors have raised funding.
Company details
Nifty Labs, established in 2005, excels in providing healthcare solutions, producing pharmaceutical products, api manufacturing, and regulatory services. Provides comprehensive solutions for API manufacturing and regulatory affairs. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
- Headquarters Hyderabad, India
- Employees 348
- Founders Kesava Reddy
- SectorsHealthcare
- Website niftylabs.com/cgi-sys/suspendedpage.cgi
- Legal Name Nifty Labs Private Limited
- Date of Incorporation 16 Mar, 2005
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹207 Cr
FY 2025 · +30% YoY
- Net Profit₹3.18 Cr
FY 2025 · 2% margin
- EBITDA₹14.45 Cr
FY 2025 · 7% margin
- Employee Count348
Associated legal entities of Nifty Labs
Nifty Labs is associated with 2 registered companies on The Company Check; the primary company is Nifty Labs Private Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Nifty Labs Private Limited CIN U24239TG2005PTC045637 | Active | 16 Mar 2005 | Hyderabad, Telangana | ₹207 Cr | 317 | 4 | View details |
| Nifty Pharma Private Limited CIN U24232TG2007PTC056705 | Active | 17 Dec 2007 | Hyderabad, Telangana | ₹13.4 Cr | 49 | 5 | View details |
Board of directors of Nifty Labs Private Limited (Nifty Labs)
Nifty Labs Private Limited is the primary company behind Nifty Labs. The boards of the 2 registered companies of Nifty Labs currently have 5 directors; the longest-serving is Kesava Reddy Desireddy, appointed in 2005. 11 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Kesava Reddy Desireddy DIN 00802977 | Managing Director | 16 Mar 2005 | 21 yrs 7 mo | Nifty Labs Private Limited, Nifty Pharma Private Limited |
| Krishna Reddy Bhimireddy DIN 00010247 | Whole-time director | 16 Mar 2005 | 21 yrs 7 mo | Nifty Labs Private Limited, Nifty Pharma Private Limited |
| Yerram Bharath Reddy DIN 00010277 | Whole-time director | 16 Mar 2005 | 21 yrs 7 mo | Nifty Labs Private Limited, Nifty Pharma Private Limited |
| Kota Venkata Reddy DIN 01824852 | Whole-time director | 17 Dec 2007 | 18 yrs 10 mo | Nifty Pharma Private Limited |
| Neha Reddy Desireddy DIN 07043585 | Director | 14 Jun 2024 | 2 yrs 4 mo | Nifty Labs Private Limited, Nifty Pharma Private Limited |
People of Nifty Labs
1 people are tracked at Nifty Labs (1 in leadership); the tracked headcount is 348.
| Name | Role | Group |
|---|---|---|
| Founder, Managing Director | Leadership |
Complete people profiles for Nifty Labs
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Nifty Labs
Figures of Nifty Labs Private Limited, the primary company behind Nifty Labs, for FY 2025. Revenue was ₹207 Cr (+30% year on year). Net profit was ₹3.18 Cr (2% margin). EBITDA was ₹14.45 Cr (7% margin). Revenue has grown at a compounded annual rate of +6% over three years and +4% over five years.
- ₹207 CrRevenue · FY 2025 · +30% YoY
- ₹3.18 CrNet profit · 2% margin
- ₹14.45 CrEBITDA · 7% margin
- ₹6.84 CrPaid-up capital
- 317Employees (provident fund records)
- +6%Revenue CAGR, 3 years
- +4%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Nifty Labs Private Limited are on its company page.
Detailed financial statements for Nifty Labs
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Nifty Labs
Nifty Labs has 9 listed competitors in our database, 2 of them funded. They include WuXi AppTec, Eurofins Scientific, Ipsen, ANI Pharmaceuticals and Red Nucleus, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| wuxiapptec.com | 2000 | Shanghai, China | $40M | 1,681 | Provider of CRO and CDMO services | |
| eurofins.com | 1987 | Luxembourg | – | – | Laboratory testing and contract research services are provided globally. | |
| ipsen.com | 1929 | – | – | 505 | Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes | |
| anipharmaceuticals.com | 1996 | Baudette, United States | – | 600 | Branded and generic prescription drugs are developed, manufactured, and marketed. | |
| rednucleus.com | 2014 | Yardley, United States | – | 176 | Advisory, scientific, and medical communications provided for pharmaceutical industry. | |
| aptar.com | 1992 | Crystal Lake, United States | – | 232 | Regulatory support, brand differentiation, and prototyping services are provided. | |
| cheplapharm.com | 1998 | Mesekenhagen, Germany | – | 840 | Branded pharmaceutical products are developed, marketed, and distributed globally. | |
| aliadatx.com | 2021 | Boston, United States | $33M | – | Provider of drug research & development services for multiple therapeutic areas | |
| cms.net.cn | 1992 | Shenzhen, China | – | – | Generic formulations including tablets, capsules, liquids, and injectables are manufactured. |
Detailed competitors of Nifty Labs
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Nifty Labs (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Nifty Labs
Complete news archive for Nifty Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nifty Labs
Nifty Labs was founded in 2005.
Nifty Labs is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Nifty Labs has 348 employees.
The primary company behind Nifty Labs, Nifty Labs Private Limited, reported revenue of ₹207 Cr for FY 2025, up 30% year on year.
Nifty Labs, established in 2005, excels in providing healthcare solutions, producing pharmaceutical products, api manufacturing, and regulatory services. Provides comprehensive solutions for API manufacturing and regulatory affairs. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
Nifty Labs's top competitors include WuXi AppTec, ANI Pharmaceuticals and Aptar.
Nifty Labs is associated with 2 legal entities: Nifty Labs Private Limited, Nifty Pharma Private Limited.
The legal entities of Nifty Labs currently have 7 directors, including Kesava Reddy Desireddy, Krishna Reddy Bhimireddy, Yerram Bharath Reddy and others.